Shimamura Takuya, Amizuka Norio, Li Minqi, Freitas Paulo H L, White John H, Henderson Janet E, Shingaki Susumu, Nakajima Tamio, Ozawa Hidehiro
Division of Reconstructive Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Biomed Res. 2005 Aug;26(4):159-72. doi: 10.2220/biomedres.26.159.
Bone tissue, with its dynamic microenvironment featuring osteoclastic bone resorption, angiogenesis and matrix degradation, appears to facilitate proliferation of tumor cells after the onset of bone metastasis. In this study, we examined metastatic lesions in the femora of BALB/c nu/nu mice two weeks after intracardiac injection with human breast carcinoma MDA-231 cells. Histopathological observations showed the metastatic lesions close to the chondro-osseous junction, and revealed MDA-231 cells loosely intermingled with different cell types such as osteoblasts, fibroblastic stromal cells, osteoclasts and endothelial cells. In the metastatic nest, many tartrate resistant acid phosphatase (TRAPase)-positive osteoclasts accumulated in direct contact with or were close to alkaline phosphatase (ALPase)- or receptor activator of NF-kappaB ligand (RANKL)-positive osteoblastic cells. It seems likely that osteoclastogenesis is mediated through cell-to-cell contacts with ALPase- and RANKL-expressing osteoblastic cells. Formation of many capillaries lacking complete basal membranes and pericytes ratified the results of in situ hybridization, which revealed intense expression of VEGF in tumor nests, and therefore, indicated ongoing tumor-induced angiogenesis. The tumor cells possessed matrix metallo-proteinases (MMPs)-1 and -9, and frequently extended their stout cytoplasmic processes into fragmented fibrillar components of the growth plate cartilage, implicating degradation of cartilaginous matrix. Thus, osteolytic bone metastasis has demonstrated pathological features as tumor-induced angiogenesis and degradation of extracellular matrix, in addition to osteoclastogenesis. This complex interplay between tumor cells and host tissues may enable and nourish the establishment of a microenvironment that facilitates tumor progression.
骨组织具有动态微环境,其特征为破骨细胞性骨吸收、血管生成和基质降解,在骨转移发生后似乎会促进肿瘤细胞的增殖。在本研究中,我们在心内注射人乳腺癌MDA - 231细胞两周后,检查了BALB/c裸鼠股骨中的转移病灶。组织病理学观察显示转移病灶靠近软骨 - 骨交界处,并发现MDA - 231细胞与成骨细胞、成纤维细胞基质细胞、破骨细胞和内皮细胞等不同细胞类型松散混合。在转移巢中,许多抗酒石酸酸性磷酸酶(TRAPase)阳性的破骨细胞聚集,与碱性磷酸酶(ALPase)或核因子κB受体激活剂配体(RANKL)阳性的成骨细胞直接接触或靠近。破骨细胞生成似乎是通过与表达ALPase和RANKL的成骨细胞的细胞间接触介导的。许多缺乏完整基底膜和周细胞的毛细血管的形成证实了原位杂交的结果,原位杂交显示肿瘤巢中VEGF表达强烈,因此表明正在进行肿瘤诱导的血管生成。肿瘤细胞具有基质金属蛋白酶(MMPs)-1和-9,并经常将其粗壮的细胞质突起延伸到生长板软骨的破碎纤维成分中,这意味着软骨基质的降解。因此,溶骨性骨转移除了破骨细胞生成外,还表现出肿瘤诱导的血管生成和细胞外基质降解的病理特征。肿瘤细胞与宿主组织之间这种复杂的相互作用可能会促成并滋养一个有利于肿瘤进展的微环境的建立。